Sichuan Kelun Pharmaceutical | Sustainability Performance
Pharmaceutical company manufacturing intravenous infusion solutions and other medical products.
1996
China
10,001+ employees
Pharmaceuticals
$1B - 10B in revenue
$100M - 500M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#10770
Overallⓘ#760
in Chinaⓘ#259
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Carbon emissionsEnergy consumptionWater ManagementAir & land impactNature and biodiversitySocial
Diversity and InclusionPay GapsExternalitiesGovernance
SDG ImpactFinancial Data
Business performanceCapital & innovationAnalyst projections
Aligned
Aligned
Controversy level
- Sichuan Kelun Pharmaceutical Co Ltd, Chinese pharmaceutical major (generic injectables), has faced sustained Chinese NMPA enforcement scrutiny over alleged inadequate disclosure of multiple injectable product quality issues at multiple Chinese production facilities including the contested 2024 sustained share price volatility amid Chinese pharma market normalization affecting Chinese institutional shareholders.
